Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Clinical trial NCT07576543 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07576543
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Older Patients Surgery Dexmedetomidine Esketamine Transcranial Direct Current Stimulation Cognitive Function Survival

Start date: 2026-06-01
Primary completion: 2030-06-01
Enrollment: 1160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.